Head Of Canadian Cannabis Giant Canopy Growth To Retire At The End Of This FY
Head Of Canadian Cannabis Giant Canopy Growth To Retire At The End Of This FY
Klein, who joined the company in January 2020, led the Ontario-based company through transformation and development to meet opportunities within the global cannabis market.Cannabis company Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced on Friday that CEO David Klein will retire after the company's current fiscal year ending March 31, 2025.
大麻股公司Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC)宣佈，首席執行官David Klein將在公司截至2025年3月31日的財年結束後退休。
Klein agreed to continue to serve in his role as CEO and as a member of the company's board of directors until this date or such time that a successor is named.
Klein同意在該日期或任何繼任者被任命的時候繼續擔任首席執行官及公司董事會成員。
The Canadian cannabis giant said its board is working on securing a search firm to initiate a CEO selection process focused on identifying the right candidate.
這家加拿大大麻巨頭表示，其董事會正在努力尋找一家搜索公司來啓動聚焦於尋找合適候選人的首席執行官選拔程序。
Klein, who joined the company in January 2020, led the Ontario-based company through transformation and development to meet opportunities within the global cannabis market.
自2020年1月加入公司以來，Klein帶領這家總部位於安大略省的公司轉型並開發，以滿足全球大麻市場的機遇。
"Under his leadership, the company established a foundation for multi-market cannabis leadership through its transformation to an asset-light model in Canada and across a range of international markets, including Germany," Canopy said in a press release. "In addition, Mr. Klein oversaw the launch and advancement of Canopy USA as a first-of-its-kind structure to offer the Company's shareholders unique exposure to the rapid growth and opportunity presented by the U.S. cannabis market ahead of federal permissibility."
Canopy表示：「在他的領導下，公司通過在加拿大和包括德國在內的一系列國際市場進行變革和發展，爲多市場大麻領導地位奠定了基礎。此外，Klein先生監督了Canopy USA的推出和發展，這是一種獨特的結構，爲公司的股東提供了在美國大麻市場上迅速增長和機會之前的獨特優勢。」
Read Also: Canopy Growth Doubles Down On Its USA Strategy, Announces Exercise of Acreage Options
閱讀更多：Canopy Growth在美國策略方面加倍努力，宣佈行使Acreage期權
Canopy recently reported a record quarter for Canadian medical marijuana, with new revenue surging 20% year-over-year and representing the 6th consecutive quarter of growth. Achieved gross profit was CA$23 million representing a 67% increase over the first quarter ended June 30, 2023, despite a decline in consolidated net revenue.
Canopy最近報告了一季度加拿大醫用大麻的創紀錄業績，新收入同比增長20％，並代表了連續第6個季度的增長。實現的毛利潤爲2300萬加元，在截至2023年6月30日的第一季度上漲了67％，儘管綜合淨收入下降。
"The fundamentals of our business continue to strengthen, and our focus on profitable revenue generation is yielding clear results as we set the stage for growth in the second half of fiscal 2025," Klein said earlier this month. "With our core businesses delivering adjusted EBITDA profitability and primed for growth, paired with Canopy USA's positioning to benefit from near-term market opportunities in the U.S., Canopy Growth is advancing rapidly and is well established for multi-market cannabis leadership."
Klein這個月早些時候表示：「我們業務的基本面繼續加強，我們專注於盈利收入的產生正在產生明顯的結果，爲我們在2025財年下半年的增長打下基礎。隨着我們的核心業務實現調整後的EBITDA盈利和爲美國市場的短期機會提供利益的Canopy USA的定位，Canopy Growth正在快速發展併爲多市場的大麻領導地位做好了充分準備。」
CGC Price Action
CGC股價行爲
Canopy's shares traded 0.14%lower at $6.97 per share during the pre-market session on Friday morning.
週五上午的盤前交易中，Canopy的股票價格爲每股6.97美元，下跌了0.14％。
Stay tuned here as Canopy moves toward choosing a new CEO.
敬請關注Canopy選擇新CEO的消息。
- Canopy Growth Expands U.S. Reach By Acquiring These Two Key Cannabis Brands
- Canopy Growth通過收購這兩個關鍵的大麻品牌擴大了其在美國的影響力